BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P1H
REFRESH-INTERVAL:P1H
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
DTSTART:20070101T000000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:Eastern Daylight Time
END:DAYLIGHT
BEGIN:STANDARD
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
DTSTART:20070101T000000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:Eastern Standard Time
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261104T171500
DTEND;TZID=America/New_York:20261104T181500
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:From Testing to Treatment: Connecting NGS Workflows to Timely Clinical Action
DESCRIPTION:FLASCO presents From Testing to Treatment: Connecting NGS Workflows to Timely Clinical Action. This educational webinar will explore practical strategies for optimizing next-generation sequencing (NGS) workflows and translating molecular testing results into timely\, informed treatment decisions for patients with metastatic non-small cell lung cancer (mNSCLC). Faculty will examine electronic medical record (EMR) and testing workflows designed to reduce turnaround times and improve the identification of actionable biomarkers. Through peer perspectives on implementation science\, participants will gain insights into navigating and interpreting NGS reports across varying formats\, integrating molecular findings with patient-specific factors\, and applying evidence-based guidelines to support personalized treatment planning. Designed for oncology healthcare professionals involved in the diagnosis and treatment of patients with mNSCLC\, this program will provide actionable strategies for bridging the gap between molecular testing and clinical decision-making.Start: 4 November 2026 5:15 pm ESTPresented in partnership with FLASCO Corporate Partner\, Boehringer Ingelheim
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE html><html><head><title></title></head><body aria-disabled="false"><p><meta charset="utf-8" /></p><p><meta charset="utf-8" /></p><p data-pm-slice="1 1 []">FLASCO presents <em>From Testing to Treatment: Connecting NGS Workflows to Timely Clinical Action</em>. This educational webinar will explore practical strategies for optimizing next-generation sequencing (NGS) workflows and translating molecular testing results into timely\, informed treatment decisions for patients with metastatic non-small cell lung cancer (mNSCLC). Faculty will examine electronic medical record (EMR) and testing workflows designed to reduce turnaround times and improve the identification of actionable biomarkers. Through peer perspectives on implementation science\, participants will gain insights into navigating and interpreting NGS reports across varying formats\, integrating molecular findings with patient-specific factors\, and applying evidence-based guidelines to support personalized treatment planning. Designed for oncology healthcare professionals involved in the diagnosis and treatment of patients with mNSCLC\, this program will provide actionable strategies for bridging the gap between molecular testing and clinical decision-making.</p><p><strong fr-original-style="" style="font-weight: 700\;">Start: 4 November 2026 5:15 pm EST</strong></p><p><em>Presented in partnership with FLASCO Corporate Partner\, Boehringer Ingelheim</em></p><p><br /></p></body></html>
LOCATION:FL
UID:e.603.1653573
SEQUENCE:3
DTSTAMP:20261111T204758Z
URL:https://members.flasco.org/calendarofevents/Details/from-testing-to-treatment-connecting-ngs-workflows-to-timely-clinical-action-1945639?sourceTypeId=Hub
END:VEVENT
END:VCALENDAR